Neurogene Inc. · NASDAQ:NGNE

McMinn Rachel exercised options for 756 Neurogene Inc. shares (Form 4)

Traded Sep 22, 2026 · Filed Oct 2, 2026

On Sep 22, 2026, McMinn Rachel (Director, Chief Executive Officer) exercised options for 756 Neurogene Inc. shares at US$25.32 for US$19,142, leaving 1,345,063 shares. Filed Oct 2, 2026 (Form 4).

Options exercised
756 shares
Price
US$25.32
Value
US$19,142
Holding after
1,345,063 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 22, 2026Common StockOption exercise756US$25.321,345,063Direct

Source

View original at SEC

Related